Cronos Group Inc

Check out how Cronos Group’s Q1 2026 earnings beat expectations, spike shares, and spark a $50 m buy‑back – but watch rising costs and volatile P/E for hidden risks.

Cronos Group’s Q4 earnings miss reveals forex‑driven earnings pressure, yet revenue beats and strategic moves—including a European acquisition and Cyprus gas project—signal growth potential.

Explore how Cronos Group’s launch of Lord Jones® in Israel and new crypto ventures bolster its global strategy and solid fundamentals for investors.

Explore why Cronos Group Inc., a top Canadian cannabis firm with strong finances and vertical integration, remains a reliable investment despite market swings.

Watch Cronos Group’s whale‑transfer surge and exec shake‑ups: new leaders, trading focus, and market gains—what it means for CRO investors.

Cronos Group partners with Crypto.com and UAE’s EmCoin to tokenise medical cannabis on its EVM, opening new blockchain‑driven revenue streams.

Explore how Cronos Group’s 2027 export launch and potential European gas deal could reshape its cannabis business and diversify revenue.

Explore how Cronos Group’s cannabis business meets crypto hype—DJT tokens, high volatility, and investor insights all in one concise market snapshot.

How Cronos Group’s €57.5 m Dutch acquisition boosts its European cannabis reach and fuels growth in a regulated market.

Explore how Cronos Group’s new ecosystem leader and $6 B Treasury launch are boosting CRO token value, driving cannabis‑crypto synergy, and unlocking growth.